Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines
We identified some effective medicines that should be evaluated for inclusion in the WHO EML. Prioritization of cancer medicines was similar between the EML and NCG India but discordant between with NCCN resource-stratified guideline.
Authors
- Brooke E. Wilson (ORCID: https://orcid.org/0000-0001-6557-7298)
- Richard Sullivan (ORCID: https://orcid.org/0000-0002-6435-1825)
- Sallie‐Anne Pearson (ORCID: https://orcid.org/0000-0001-7137-6855)
- Lorenzo Moja (ORCID: https://orcid.org/0000-0001-6680-6507)
- Bishal Gyawali (ORCID: https://orcid.org/0000-0001-7444-8594)
- C.S. Pramesh (ORCID: https://orcid.org/0000-0002-3635-0083)
- Michael Bartoň (ORCID: https://orcid.org/0000-0003-0112-0680)
- Kristin Wright (ORCID: https://orcid.org/0000-0003-0297-2041)
- Elisabeth G.E. de Vries (ORCID: https://orcid.org/0000-0002-8949-7425)
- Manju Sengar (ORCID: https://orcid.org/0000-0002-3509-5682)
- Christopher M. Booth (ORCID: https://orcid.org/0000-0002-1353-3653)
Institutions
- New South Wales Department of Health (AU)
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Homi Bhabha National Institute (IN)
- Queen's University (CA)
- UNSW Sydney (AU)
- Menzies School of Health Research (AU)
- London Cancer (GB)
- World Health Organization (CH)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1093/jnci/djaf100
- Citations
- 2
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 6.26
Funders
- Queen's University